Undervalued Copper Stock could Be Set for Another 600% Run
Small Company, Big Profit Opportunity in America's Hottest Mining Spot

This may be one of the most undervalued copper stocks on the market
Get the insider scoop!

AVE Insider Trading (Avecho Biotechnology)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Avecho Biotechnology Insider Trading History Chart

This chart shows the insider buying and selling history at Avecho Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avecho Biotechnology Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 06/1/2021 01:08 PM ET

This chart shows the closing price history over time for AVE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Unicorn Alert: This Strange Gas Poses a HUGE Problem For Semiconductors…
This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. That's why this one company could explode over 2021.
Click Here To See This Incredibly Valuable Gas

Avecho Biotechnology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2021Gregory (Greg) CollierInsiderExpiry2,250,000A$0.02A$40,500.00
5/31/2021Matthew McNamaraInsiderIssued3,993,644A$0.02A$75,879.24
See Full Table
Insider Trading at Avecho Biotechnology?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Avecho Biotechnology and related companies.

SEC Filings (Institutional Ownership Changes) for Avecho Biotechnology (ASX:AVE)

Avecho Biotechnology logo
Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, animal health, and nutrition industries in Australia and internationally. The company operates through Production, Human Health, and Other segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 is based in Clayton, Australia.
Read More on Avecho Biotechnology

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Avecho Biotechnology?

Avecho Biotechnology's top insider investors include:
  1. Gregory (Greg) Collier (Insider)
  2. Matthew McNamara (Insider)
Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can't keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company's shares sky-high.
Get all the details on this potential blockbuster!